Draft Evidence Report
Midwest CEPAC

PDF cover

MS: Draft Evidence Report

ICER’s Draft Evidence Report on siponimod for treatment of secondary progressive MS, open to public comment until April 10, 2019 at 5pm ET. For more information on submitting a public comment, please visit our stakeholder engagement page.


View All Materials on this Topic or Go Back to View More Materials